Roswell Park Receives $1 Million for Race Differences in Prostate Cancer

Roswell Park Receives Nearly $1 Million to Address Race-Related Disparities in Prostate Cancer Grants from Department of Defense and American Cancer Society fund efforts to develop better tests and therapies African American men have highest rates of prostate cancer, and worst outcomes One study will investigate genetic

Read more

Advice from a Prostate Cancer Survivor: MANUP and Put Aside Your Fears!

Courtesy of Roswell Park Cancer Talk Blog Richard Satterwhite encourages men to join him in an important club — Men Allied for the Need to Understand Prostate Cancer (MANUP Buffalo). Now a Patient Engagement Specialist at Roswell Park Comprehensive Cancer Center (Roswell), Satterwhite considers himself lucky to

Read more

Prostate MRI for Cancer Evaluation: Invaluable Information for Patients at Risk

by David Cipolla, M.D. The prostate is a small walnut-shaped gland in males that produces the seminal fluid that transports sperm. After skin cancer, prostate cancer is the most common type of cancer in men. Many prostate cancers grow slowly without causing serious harm, but others are

Read more

Developing A New Screening Test for Prostate Cancer

Courtesy of Roswell Park Comprehensive Cancer Center Each year millions of men get a prostate-specific antigen (PSA) test to detect signs of prostate cancer in their blood. The PSA test, created at Roswell Park Comprehensive Cancer Center after PSA was identified in the 1970s, detects elevated levels of a

Read more

Roswell Identifies Gene Linked to Aggressive Prostate Cancer Tumors

Roswell Park Team Identifies Potential Biomarker for Aggressive Prostate Cancer – Late-breaking research presented at AACR annual meeting in Washington, D.C. – Gene linked to aggressive prostate cancer tumors Identifying a gene linked to aggressive prostate cancer tumors may help oncologists to identify aggressive prostate tumors sooner, and additional

Read more

Guiding Treatment Decisions in Prostate Cancer

One Single Biopsy Not Sufficient to Guide Treatment Decisions in Prostate Cancer – Molecular composition of multiple tumors shows genomic differences Cleveland, OH & Buffalo, NY – While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal. That fact underscores both

Read more